The scope of the global Antacids Market was appreciated at US$ 5.83 billion in 2017. The range is projected to touch US$ 7.91 billion by 2025, growing at a CAGR of 3.9% for the duration of the forecast. This could be due to increase in geriatric population encountering GERD (Gastroesophageal reflux disease), poor eating habits causing acidity, and the ill-effects of anti-inflammatory, non-steroidal drugs.
Request a Sample PDF Copy of This Report @ https://www.millioninsights.com/industry-reports/antacids-market/request-sample
Market Synopsis of Antacids Market:
It’s a known fact that amongst
the elderly populace, there is a recurrence of acidic complications. This comes
across as a challenge for gastroenterologist as well as the primary care
provider. Plus, these patients do suffer from disorders like erosive
esophagitis, esophageal cancer, and Barrett esophagus. The treatment herein
needs an amalgamation of therapies. This is where antacids come into picture.
Besides, growth in e-Commerce is
expected to drive demand for antacids via online retailing channels in the
subsequent years. In other words, growing popularity on the part of e-Commerce
coupled with increase in online medicine providers is expected to bolster the
market. At the same time, restraints do exist in the form of intake by young
children. “Gut” journal states that young children displayed obesity symptoms
on intake of antacids. As far as infants are concerned, antacids are a strict
“no-no”. Even during pregnancy antacids should be avoided as chances of
pre-mature birth can’t be ruled out.
The antacids market is segmented
on the basis of drug class, type of formulation, distribution channel, and
geography. By drug class, the segmentation spans proton pump inhibitors, H2
antagonist (interventional/surgical simulators), and acid neutralizers. By type
of formulation, the antacids industry comprises tablet, liquid, and powder. By
distribution channel, it consists of retail pharmacies, hospital pharmacies,
and the other distribution channels. By geography, the antacid market is
segmented into North America, LATAM, Asia Pacific, Europe, and MEA.
The players contributing to the
antacids market include Bayer AG, AstraZeneca PLC, Sanofi S.A., Reckitt
Benckiser Group PLC, Procter & Gamble, Pfizer Inc., Johnson & Johnson,
and Dr. Reddy’s Laboratories Ltd.
View Full Table of Contents of This Report @ https://www.millioninsights.com/industry-reports/antacids-market
Table of Contents:-
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Antacids: Market
Variables, Trends & Scope
Chapter 4 Antacids: Product
Estimates & Trend Analysis
Chapter 5 Antacids: Application
Estimates & Trend Analysis
Chapter 6 Antacids: End-use
Estimates & Trend Analysis
Chapter 7 Antacids: Industrial
End-use Estimates & Trend Analysis
Chapter 8 Antacids: Regional
Estimates & Trend Analysis
Chapter 9 Competitive Landscape
Chapter 10 Antacids:
Manufacturers Company Profiles
Get in touch
At Million Insights, we work with
the aim to reach the highest levels of customer satisfaction. Our
representatives strive to understand diverse client requirements and cater to
the same with the most innovative and functional solutions.
No comments:
Post a Comment